Nihon Nohyaku Co., Ltd. engages in the manufacture of agrochemical and pharmaceutical products. It operates through the following segments: Agrochemical, Chemical Products (except agrochemical), and Others. The Agrochemical segment produces and sells insecticides, fungicides, herbicides, pesticides, and other agrochemicals. The Chemical Products segment manufactures and distributes wood chemicals, water treatment agents, agrochemical materials, and pharmaceutical products. The Others segment deals with landscaping and greening construction, real estate leasing, logistics services, and pesticide residue analysis. The company was founded on November 17, 1928 and is headquartered in Tokyo, Japan.

Pola Pharma, Inc. engages in the research, development, manufacture, sale and import of medicine, quasi-drugs and cosmetics. The company was founded on January 5, 2007 and is headquartered in Tokyo, Japan.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

TOPICA Pharmaceuticals, Inc. is a privately held clinical research stage pharmaceutical company focused on developing luliconazole for the treatment of onychomycosis, fungal infections of the nail. More than 35 million Americans are estimated to suffer from onychomycosis for which treatment options are limited. In addition to luliconazole’s highly potent anti-fungal activity and excellent safety profile, the molecule is able to rapidly cross the nail plate reaching the site of the infection in the nail bed. In a Phase 1/2a clinical trial completed in 2011, TOPICA demonstrated the ability of its 3 proprietary 10 percent luliconazole solution to rapidly cross the nail plate and was well tolerated by patients. The company is now focused on conducting a robust dose finding and proof of efficacy study with luliconazole in onychomycosis starting in mid 2012 with the goal of making luliconazole the first highly effective and safe topical therapy for the treatment of onychomycosis.

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.

Sichuan Haisco Pharmaceutical Co., Ltd., established on 2003-09-29, Business scope includes licensed projects:pharmaceutical production;Drug import and export;Pharmaceutical commissioned production;Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Import and export;Technology Import and Export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Shanghai Cai'erwen Biochemical Technology Co., Ltd, established on 2004-12-06, Business scope includes food,biology,medicine,chemical industry,Technology research and development in the field of new materials,technical consulting,technology transfer,Technical Services,food sales,Packaging Materials,nanomaterials,Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)promotion of,The following limited branch operations:engaged in vitamin products,Experimental research and production of ophthalmic intermediates. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Zenvision Pharma specializes in formulation development, contract manufacturing, R&D, and technology transfer services.

Optimus Drugs Pvt Ltd. engages in the manufacture of pharmaceutical products. It offers antihyperparathyroid, antidepressant, antifungal, antithrombotic, anticonvulsant, antibacterial, antipsychotic, antiretroviral, protease inhibitor, and aldosterone antagonist. The company was founded by Srinivasa Reddy in 2004 and is headquartered in Hyderabad, India.

Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.

Alkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals. The company was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973 and is headquartered in Mumbai, India.

Maruho Co., Ltd. engages in the research, development, manufacture, and marketing of pharmaceutical products. It specializes in the production of dermatology and topical drugs. Its products include Hirudoid Cream, Eksalb, Rozex Gel, Casal Cream, Farom Tablets, and Telgin G Dry Syrup. The company was founded by Eikuma Koba in July 1915 and is headquartered in Osaka, Japan.

Viwit Pharmaceuticals develops, manufactures, and distributes new products in the fields of finished dosage formulations, active pharmaceutical ingredients, and fine chemicals. they progressed from developing chiral borane compounds to producing drug intermediates, active pharmaceutical substances, and biopharmaceutical products.

Shandong Weizhi Zhongke Pharmaceutical Co., Ltd., established on 2006-11-10, Business scope includes technology development in the field of biomedicine,technical consulting,Technical Services,technology transfer;solid preparations(tablet,Capsules,Granules)production and sales of;Engaged in import and export of goods and technology.(involving administrative licensing,The validity period is subject to the license;Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Glenmark Life Sciences Ltd. engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

Shanghai Weizhi Pharmaceutical Technology Co., Ltd., established on 2006-07-19, Business scope includes biological,Technology development in the field of medical expertise,technical consulting,Technical Services,technology transfer,biological reagent(except medical,Diagnostic reagents),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)production and sales of,Engaged in the import and export of goods and technology.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shandong Weizhi Baike Pharmaceutical Co., Ltd., established on 2000-10-31, Business scope includes biological,Technical research and development in the field of medicine,technical consulting,Technical Services,technology transfer;Chemical API(Does not contain hazardous chemicals),Manufacture and sales of formulations;And engaged in the import and export of goods and technology import and export business(Does not contain publications and items prohibited by national policies).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Kimia Biosciences Ltd. engages in the manufacture and distribution of pharmaceutical products. It offers bulk drug intermediates and active pharmaceutical ingredients. The company was founded on September 27, 1993 and is headquartered in New Delhi, India.

Shanghai Fuller Pharmaceutical Technology Co., Ltd., established on 2014-07-16, Business scope includes biotechnology,Technology development in the field of medical science and technology,technical consulting,Technical Services,technology transfer(Do not engage in medical activities,psychological counseling),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)production and sales of,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]